CoaguChek^® monitoring systems empower healthcare professionals to make immediate, knowledge-based adjustments of anticoagulation therapy with minimum inconvenience to their patients:

CoaguChek^® testing at the point of care for :

• Better patient care and quality of life^1,2
• Optimized healthcare workflows
• Anticoagulation therapy for patient subgroups with special conditions
  • Patients with severe renal impairment³
  • Patients with increased risk of bleeding and gastrointestinal side effects
  • Patients with mechanical heart valves at high risk of stroke ^3,4,5

Discover our products :

• CoaguChek^® INRange
• CoaguChek^® XS Plus system
• CoaguChek^® XS Pro system 
• CoaguChek® Pro II

References :

1. Heneghan et al (2012). Lancet 379:292-293

2. Heneghan C, et al: Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367:404-411

3. Wann LS, et al. 2011 ACCF/AHA/HRS A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011;57:1330-1337

4. Fuster Valentin, et al: 2011 ACCF/AHA/HRS focused updates incorporated into the ADDF/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2011;123:269-367

5. Connolly SJ,et al: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139-1151